drugset / Trial / NCT02674412

Buspirone for Functional Dysphagia

NCT02674412

Completed 10 enrolled The Cleveland Clinic
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study evaluates the utility of buspirone in patients who have a diagnosis of functional dysphagia. All participants will be randomized to receive either a placebo pill or buspirone. Subsequently, we will evaluate whether their swallowing is improved. Participants who were randomized to receive placebo will then receive buspirone and those who were receiving buspirone will receive placebo. We will again evaluate whether their swallowing improved.

Timeline

Start
2016-02
Primary completion
2017-04-12
Completion
2017-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Buspirone Small molecule 10 mg Oral